Attenuated Live Triple G Protein Recombinant Rabies Virus Vaccine for Pre- and Post-Exposure Prophylaxis of Rabies

• 1. 狂犬病暴露后紧急处理和发病早期紧急治疗的药物及制备方法 [P] . 中国专利： CN101011582B . 2010.05.12
• 2. 狂犬病暴露后紧急处理和发病早期紧急治疗的药物及制备方法 [P] . 中国专利： CN101011582A . 2007-08-08
• 3. Attenuated live triple G protein recombinant rabies virus vaccine for pre- and post-exposure prophylaxis of rabies [P] . 美国专利： US8282939B2 . 2012-10-09

  机译： 减毒活三联G蛋白重组狂犬病毒疫苗，用于狂犬病暴露前和暴露后的预防

• 4. Recombinant Mutant Rabies Virus, Mutant, Recombinant Rabies Virus, and, Attenuated Live Rabies Vaccine [P] . BR0201366A . 2003-06-10

  机译： 重组狂犬病病毒，突变狂犬病病毒和减毒活狂犬病疫苗

• 5. A Mutant of recombinant Rabies virus, Rabies Vaccine and a Live Attenuated virus [P] . AR021406A1 . 2002-07-17

  机译： 重组狂犬病病毒，狂犬病疫苗和减毒活病毒的突变体

• 1. Causes of delay in offering rabies post-exposure prophylaxis services in Abadeh district of Iran [J] . Ahmad Karimi, Behnam Karimi, Ahmad Karimifard, 急性病杂志（英文版） . 2020,第001期
• 2. Causes of delay in offering rabies post-exposure prophylaxis services in Abadeh district of Iran [J] . Ahmad Karimi, Behnam Karimi, Ahmad Karimifard, 急性病杂志(英文版) . 2020,第001期
• 3. Generation of recombinant rabies virus ERA strain applied to virus tracking in cell infection [J] . ZHAO Dan-dan, SHUAI Lei, GE Jin-ying, 农业科学学报：英文版 . 2019,第010期
• 4. Generation of recombinant rabies virus ERA strain applied to virus tracking in cell infection [J] . ZHAO Dan-dan, SHUAI Lei, GE Jin-ying, 农业科学学报（英文版） . 2019,第010期
• 5. Safety and immunogenicity of chromatographically purified Vero cell rabies vaccine for intradermal pre- And post-exposure rabies prophylaxis [J] . TantawichienT., SibunruangS., AngsanakulJ., Expert review of vaccines . 2014,第12期
• 6. Safety and immunogenicity of chromatographically purified Vero cell rabies vaccine for intradermal pre- And post-exposure rabies prophylaxis [J] . TantawichienT., SibunruangS., AngsanakulJ., Expert review of vaccines . 2014,第12期
• 7. Live vaccinia-rabies virus recombinants, but not an inactivated rabies virus cell culture vaccine, protect B-lymphocyte-deficient A/WySnJ mice against rabies: considerations of recombinant defective poxviruses for rabies immunization of immunocomprom [J] . Lodmell DL, Esposito JJ, Ewalt LC Vaccine . 2004,第25a26期
• 8. Canine adenovirus antibodies in meso-carnivores in the United States of America: implications for oral rabies vaccination using recombinant adenovirus vaccines? [C] . D. Slate, T. P. Algeo, E.H. Oertli, The OIE Global Conference on Rabies Control . 2012
• 9. Expression of interferon gamma by recombinant rabies virus strongly attenuates virus pathogenicity and enhances safety and efficacy of post-exposure treatment vectors. [D] . Barkhouse, Darryll. 2014
• 10. Pre- and post-exposure safety and efficacy of attenuated rabies virus vaccines are enhanced by their expression of IFNγ [O] . Darryll A. Barkhouse, Milosz Faber, D. Craig Hooper -1
• 11. Pre- and post-exposure safety and efficacy of attenuated rabies virus vaccines are enhanced by their expression of IFNγ [O] . Barkhouse Darryll A., Faber Milosz, Hooper D. Craig 2015

• 1. Success Story of a Low Cost Intra-Dermal Rabies Vaccination (IDRV) Clinic-Lessons Learnt over Five Years of 12,000 Patient Vaccinations “Without Failure” at DDU Hospital Shimla, Himachal Pradesh, India br/—“Saving a Drop of Rabies Vaccine and Immunoglobulins” 12 Innovations to Make Himachal Pradesh Rabies Free State by 2020 [J] . Omesh Kumar Bharti ,Shampur Narayan Madhusudana ,Ashok Kale . 疫苗（英文） . 2015,第3期
• 2. 3126例狂犬病暴露人群预防处理分析 [C] . 蒋志勤 . 2010全国狂犬病防控高层论坛 . 2010
• 3. Ⅰ：抗狂犬病毒单抗对狂犬病街毒暴露后的治疗;Ⅱ：细胞培养法检测和分离狂犬病街毒的可行性研究 [A] . 汪霞 . 2008